Name Net closed
positions
Closed positions New positions Return since
31 Mar ‘22
626
13 27 14 99.6%
627
13 27 14 58.1%
628
13 26 13 687%
LCTX icon
629
Lineage Cell Therapeutics
LCTX
$409M
13 25 12 16.2%
630
13 25 12 17.2%
631
13 25 12 96.3%
632
13 24 11 69%
633
13 24 11 7.2%
634
13 23 10 92.3%
635
13 22 9 80.1%
BRW
636
Saba Capital Income & Opportunities Fund
BRW
$317M
13 20 7 17.5%
637
13 20 7 79.8%
638
13 20 7 84.4%
639
13 19 6 14.4%
640
13 19 6 17.4%
641
13 18 5 38.7%
642
13 16 3 92.4%
643
13 16 3 43.4%
644
13 15 2 7.22%
645
12 184 172 5.74%
646
12 117 105 22.5%
647
12 116 104 22.3%
648
12 96 84 25.9%
649
12 90 78 59.4%
650
12 79 67 59.1%